TY - JOUR
T1 - Dental Management for People With Congenital Haemophilia
T2 - A Systematic Review of the Existing Dental Recommendations
AU - Kumar, Mathangi
AU - Badagabettu, Sulochana
AU - Pai, Keerthilatha M.
AU - Angelitta Noronha, Judith
AU - Nayak, Baby S.
AU - McCarthy, Penny
N1 - Publisher Copyright:
© 2025 The Author(s). Haemophilia published by John Wiley & Sons Ltd.
PY - 2025
Y1 - 2025
N2 - Introduction: Haemophilia is the most common inherited bleeding disorder. Dental management for people with haemophilia (PwH) (both A and B) is challenging, as dental procedures may initiate bleeding episodes that may be difficult to control. Objectives: This systematic review aimed to evaluate and summarize the existing dental guidelines that are proposed from various agencies/professional bodies, and so forth, for dental treatment procedures in PwH. Methods: A systematic electronic search on databases like Scopus, Medline, EMBASE, CINAHL, ProQuest and Web of Science was performed. The parameters evaluated were (a) clotting factor replacement therapy employed, (b) haemostatic agents, both local and systemic therapy and (c) dental procedural and pharmacological considerations that are recommended before, during, and after dental treatment procedures for people with mild, moderate and severe haemophilia. The dental treatment procedures included all minor and major procedures, including surgical extraction of wisdom teeth. Results: A total of 11 guidelines were included for data extraction. The results indicated that all guidelines emphasized the importance of close collaboration among haematologists and dental professionals to ensure safe and effective dental treatment as a key component of comprehensive dental care. The various dental treatments (restorative, periodontal, orthodontic and prosthodontic treatments) and preventive aspects of oral health are detailed. Also, the amount of clotting factor replacement therapy for dental procedures, and pharmacological considerations recommended from the various professional organizations are discussed. Conclusion: Well-designed large-scale research initiatives in dental management for PwH are necessary to understand the applicability and outcomes of such guidelines in clinical practice. Trial Registration: REF/2024/01/077096.
AB - Introduction: Haemophilia is the most common inherited bleeding disorder. Dental management for people with haemophilia (PwH) (both A and B) is challenging, as dental procedures may initiate bleeding episodes that may be difficult to control. Objectives: This systematic review aimed to evaluate and summarize the existing dental guidelines that are proposed from various agencies/professional bodies, and so forth, for dental treatment procedures in PwH. Methods: A systematic electronic search on databases like Scopus, Medline, EMBASE, CINAHL, ProQuest and Web of Science was performed. The parameters evaluated were (a) clotting factor replacement therapy employed, (b) haemostatic agents, both local and systemic therapy and (c) dental procedural and pharmacological considerations that are recommended before, during, and after dental treatment procedures for people with mild, moderate and severe haemophilia. The dental treatment procedures included all minor and major procedures, including surgical extraction of wisdom teeth. Results: A total of 11 guidelines were included for data extraction. The results indicated that all guidelines emphasized the importance of close collaboration among haematologists and dental professionals to ensure safe and effective dental treatment as a key component of comprehensive dental care. The various dental treatments (restorative, periodontal, orthodontic and prosthodontic treatments) and preventive aspects of oral health are detailed. Also, the amount of clotting factor replacement therapy for dental procedures, and pharmacological considerations recommended from the various professional organizations are discussed. Conclusion: Well-designed large-scale research initiatives in dental management for PwH are necessary to understand the applicability and outcomes of such guidelines in clinical practice. Trial Registration: REF/2024/01/077096.
UR - https://www.scopus.com/pages/publications/105013572378
UR - https://www.scopus.com/pages/publications/105013572378#tab=citedBy
U2 - 10.1111/hae.70104
DO - 10.1111/hae.70104
M3 - Review article
AN - SCOPUS:105013572378
SN - 1351-8216
VL - 31
SP - 830
EP - 839
JO - Haemophilia
JF - Haemophilia
IS - 5
ER -